A biological product is not an automatic guarantee of a higher yield. Its economic value depends on the crop, soil, weather scenario, application technology and the price of the result. For an agricultural producer, it is important to evaluate not the advertising promise, but the additional effect in a specific field: does it cover the cost of the product, labor, logistics and the risk of an unstable result.
In a simple model, a solution is justified if the additional marginal revenue from treatment exceeds the total additional costs. These include not only the price of the canister, but also water, fuel, depreciation of the equipment, labor costs, compatibility with the tank mix, and possible losses from errors in application timing. Therefore, the same technology may be appropriate in a field with high stress and redundant in a field where the limiting factor is moisture or nutrient deficiency.
The key indicator is not the average increase from the demonstration plot, but the probability of obtaining the result in your own production scenario. The calculation should include the price of grain or other products, base yield, area, costs for repeated operations, and a conservative scenario with no effect.
| Stage | What we check | Strength | Limitation |
|---|---|---|---|
| Controlled trial | The difference between options with the same technology | The causal effect is better seen | Few soils and seasons |
| Pilot in the farm | Compatibility with real-world equipment and operations | The result is closer to production conditions | Repetitions and correct control are needed |
| Scaling | Stability of the effect in different fields | Shows the risk and logistics of a large area | More expensive and more sensitive to field heterogeneity |
The FAO describes field and on-farm trials as a way to adapt recommendations to local constraints, as soils, weather and management practices vary from field to field (FAO: Why do research on-farm?). For regulatory efficacy assessments, it is also important that the trial conditions are appropriate for the specific crop, pest or agronomic task, and that doses and controls are described transparently (FAO: efficacy trials).
A systematic review of open field trials of biostimulants shows that crop response varies with environmental conditions and agronomic management; the authors explicitly caution against extrapolating average effects to each field (A meta-analysis of biostimulant yield effectiveness in field trials). Separate reviews for maize and studies under water stress find positive signals, but at the same time highlight the heterogeneity of methods, crops, doses and weather conditions (systematic review for maize).
Це не означає, що біопрепарати не працюють. Це означає, що твердження про ефективність має бути прив’язане до культури, сорту, фази розвитку, способу внесення та стресового чинника.
If the effect is only evident in a single stress scenario, this is not a drawback – it is a condition of use that should be honestly included in the technological map. If the data is unstable, it is safer to leave the drug in the pilot and not budget its result as guaranteed.
The effectiveness of biologics in agriculture should be assessed as a risk management approach: through a local controlled pilot, full cost of the operation, and a predetermined success criterion. This approach helps the agroholding separate a technology with recurring benefits from a one-time positive coincidence of conditions.
CTA: If you have crop, field, and product data, prepare a short pilot protocol and coordinate it with an agronomist and AVELife science specialist before scaling up.
No. The result depends on the crop, soil, weather, stress and technology. Local repeat trials are required.
Minimally, untreated control in a comparable part of the field. For a more correct solution, standard management technology and repetitions are added.
Do not include the expected effect in the guaranteed budget. Continue the pilot, collect costs and yields using the same methodology, and check the result in the next season.
Land restoration as an investment project: how to define a baseline, assess environmental and financial impact, take risks into account, and build a verifiable system of indicators without overpromises.
A balanced review of the potential of sapropel for soil restoration: what research shows, what tests are needed, and why there is no universal standard.
Restoration of degraded soils: why one method is not enough A degraded area often looks “obvious”: topsoil washout, compaction, uneven slopes, or water stagnation. However,…
